Pubblicazioni

Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

2019 - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Marampon, Francesco; Leoni, Flavio; Mancini, Andrea; Pietrantoni, Ilaria; Codenotti, Silvia; Letizia, Ferella; Megiorni, Francesca; Porro, Giuliana; Galbiati, Elisabetta; Pozzi, Pietro; Mascagni, Paolo; Budillon, Alfredo; Maggio, Roberto; Tombolini, Vincenzo; Fanzani, Alessandro; Gravina, Giovanni Luca; Festuccia, Claudio

The possible prognostic role of histone deacetylase and transforming growth factor Î²/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study

2017 - EUROPEAN JOURNAL OF HISTOCHEMISTRY

Sferra, Roberta; Pompili, Simona; Festuccia, Claudio; Marampon, Francesco; Gravina, Giovanni L.; Ventura, Luca; Di Cesare, Ernesto; Cicchinelli, Sara; Gaudio, Eugenio; Vetuschi, Antonella

Emerging approaches for histone deacetylase inhibitor drug discovery

2015 - EXPERT OPINION ON DRUG DISCOVERY

Zwergel, Clemens; Valente, Sergio; Jacob, Claus; Mai, Antonello

Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity

2015 - EUROPEAN NEUROPSYCHOPHARMACOLOGY

Erburu, M.; MuÃ±oz Cobo, I.; DomÃnguez AndrÃ©s, J.; Beltran, E.; Suzuki, T.; Mai, Antonello; Valente, Sergio; Puerta, E.; Tordera, R. M.